Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00370331 · OUTCOME

Percentage of Participants Initiating Rescue Treatment On-therapy

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag · Source last updated 2017-04-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of participants
Interval / dispersion
Not reported
Time frame
Anytime from Day 1 to Week 26

What was measured

Percentage of participants initiating new ITP medication, an increased dose of concomitant ITP medication from baseline, platelet transfusion, or splenectomy.

Analysis population: All participants randomized to receive placebo or eltrombopag treatment

Groups in this outcome

Placebo

Matching placebo tablets taken once a day

Eltrombopag 50 mg QD

Eltrombopag 50 mg oral tablets taken once a day (QD)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Placebo62
Eltrombopag 50 mg QD135

Reported measurements

Participants who received rescue treatment
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Placebo40Not reportedNot reportedNot reportedNot reported
Eltrombopag 50 mg QD18Not reportedNot reportedNot reportedNot reported
Participants who did not receive rescue treatment
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Placebo60Not reportedNot reportedNot reportedNot reported
Eltrombopag 50 mg QD82Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        40
      2. group Id
        OG001
        value
        18
    title
    Participants who received rescue treatment
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        60
      2. group Id
        OG001
        value
        82
    title
    Participants who did not receive rescue treatment
denoms
  1. counts
    1. group Id
      OG000
      value
      62
    2. group Id
      OG001
      value
      135
    units
    Participants
description
Percentage of participants initiating new ITP medication, an increased dose of concomitant ITP medication from baseline, platelet transfusion, or splenectomy.
groups
  1. description
    Matching placebo tablets taken once a day
    id
    OG000
    title
    Placebo
  2. description
    Eltrombopag 50 mg oral tablets taken once a day (QD)
    id
    OG001
    title
    Eltrombopag 50 mg QD
param Type
NUMBER
population Description
All participants randomized to receive placebo or eltrombopag treatment
reporting Status
POSTED
time Frame
Anytime from Day 1 to Week 26
title
Percentage of Participants Initiating Rescue Treatment On-therapy
type
SECONDARY
unit Of Measure
Percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice